How to better stratify the risk of differentiated thyroid carcinomas: the key role of radioactive iodine therapy, age, and gender

被引：0

作者：

Arnoldo Piccardo

Giacomo Siri

Stefano Raffa

Marco Castellana

Luca Foppiani

Gianluca Bottoni

Martina Ugolini

Angelina Cistaro

Ugo Catrambone

Vania Altrinetti

Michela Massollo

Anselmo Arlandini

Luca Giovanella

Manlio Cabria

Pierpaolo Trimboli

机构：

[1] E.O. “Ospedali Galliera”,Department of Nuclear Medicine

[2] University of Genoa,Department of Mathematics

[3] Galliera Hospital,Scientific Directorate

[4] IRCCS Ospedale Policlinico San Martino,Nuclear Medicine Unit

[5] National Institute of Gastroenterology “Saverio De Bellis”,Department of Internal Medicine

[6] E.O. “Ospedali Galliera”,Department of Surgery

[7] Galliera Hospital,Clinic for Nuclear Medicine and Competence Center for Thyroid Diseases, Imaging Institute of Southern Switzerland

[8] Ente Ospedaliero Cantonale,Clinic for Nuclear Medicine

[9] University Hospital and University of Zurich,Faculty of Biomedical Sciences

[10] Università della Svizzera Italiana (USI),undefined

来源：

European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷

关键词：

DTC; Risk stratification; RAI; Elderly; Gender;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：822 / 830

页数：8

共 50 条

[41] The Role of Radioactive Iodine Therapy in Young Patients With Papillary Thyroid Cancer
Kuo, Sheng-Fong
Chao, Tzu-Chieh
Chang, Hung-Yu
Hsueh, Chuen
Chang, Yu-Chen
Yang, Chung-Han
Lin, Jen-Der
CLINICAL NUCLEAR MEDICINE, 2009, 34 (01) : 4 - 10
[42] Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer
An, Jee Hyun
Song, Kee-Ho
Kim, Dong-Lim
Kim, Suk Kyeong
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2017, 45 (01) : 38 - 50
[43] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
Zhang, Lu
Li, Zhi
Zhang, Meng
Zou, Huangren
Bai, Yuke
Liu, Yanlin
Lv, Juan
Lv, Ling
Liu, Pengjie
Deng, Zhiyong
Liu, Chao
MEDICAL ONCOLOGY, 2023, 40 (09)
[44] Advances in the molecular mechanism and targeted therapy of radioactive-iodine refractory differentiated thyroid cancer
Lu Zhang
Zhi Li
Meng Zhang
Huangren Zou
Yuke Bai
Yanlin Liu
Juan Lv
Ling Lv
Pengjie Liu
Zhiyong Deng
Chao Liu
Medical Oncology, 40
[45] OPTIMIZING LENVATINIB THERAPY IN PATIENTS WITH METASTATIC RADIOACTIVE IODINE-RESISTANT DIFFERENTIATED THYROID CANCERS
Jasim, Sina
Iniguez-Ariza, Nicole M.
Hilger, Crystal R.
Chintakuntlawar, Ashish V.
Ryder, Mabel M.
Morris, John C., III
Bible, Keith C.
ENDOCRINE PRACTICE, 2017, 23 (10) : 1254 - 1261
[46] Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Mei, Xiaoran
Yao, Xiaoqin
Feng, Fang
Cheng, Weiwei
Wang, Hui
BMC CANCER, 2021, 21 (01)
[47] Risk and outcome of subsequent malignancies after radioactive iodine treatment in differentiated thyroid cancer patients
Xiaoran Mei
Xiaoqin Yao
Fang Feng
Weiwei Cheng
Hui Wang
BMC Cancer, 21
[48] Impact on Overall Survival of Radioactive Iodine in Low-Risk Differentiated Thyroid Cancer Patients
Schvartz, Claire
Bonnetain, Franck
Dabakuyo, Sandrine
Gauthier, Melanie
Cueff, Adele
Fieffe, Sandrine
Pochart, Jean-Marie
Cochet, Inna
Crevisy, Elodie
Dalac, Audrey
Papathanassiou, Dimitri
Toubeau, Michel
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (05): : 1526 - 1535
[49] Estimation of Second Primary Cancer Risk After Treatment with Radioactive Iodine for Differentiated Thyroid Carcinoma
Correa, Nilton Lavatori
de Sa, Lidia Vasconcellos
Ramalho de Mello, Rossana Corbo
THYROID, 2017, 27 (02) : 261 - 270
[50] Well-differentiated thyroid carcinoma: The role of post-operative radioactive iodine administration
Patel, Supriya S.
Goldfarb, Melanie
JOURNAL OF SURGICAL ONCOLOGY, 2013, 107 (06) : 665 - 672

← 1 2 3 4 5 →